193 related articles for article (PubMed ID: 17916591)
1. Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response.
Madoz-Gúrpide J; Kuick R; Wang H; Misek DE; Hanash SM
Mol Cell Proteomics; 2008 Feb; 7(2):268-81. PubMed ID: 17916591
[TBL] [Abstract][Full Text] [Related]
2. Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens.
Qiu J; Madoz-Gurpide J; Misek DE; Kuick R; Brenner DE; Michailidis G; Haab BB; Omenn GS; Hanash S
J Proteome Res; 2004; 3(2):261-7. PubMed ID: 15113102
[TBL] [Abstract][Full Text] [Related]
3. Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity.
Bouwman K; Qiu J; Zhou H; Schotanus M; Mangold LA; Vogt R; Erlandson E; Trenkle J; Partin AW; Misek D; Omenn GS; Haab BB; Hanash S
Proteomics; 2003 Nov; 3(11):2200-7. PubMed ID: 14595819
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.
Qiu J; Choi G; Li L; Wang H; Pitteri SJ; Pereira-Faca SR; Krasnoselsky AL; Randolph TW; Omenn GS; Edelstein C; Barnett MJ; Thornquist MD; Goodman GE; Brenner DE; Feng Z; Hanash SM
J Clin Oncol; 2008 Nov; 26(31):5060-6. PubMed ID: 18794547
[TBL] [Abstract][Full Text] [Related]
5. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.
Brichory FM; Misek DE; Yim AM; Krause MC; Giordano TJ; Beer DG; Hanash SM
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9824-9. PubMed ID: 11504947
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3.
Nam MJ; Madoz-Gurpide J; Wang H; Lescure P; Schmalbach CE; Zhao R; Misek DE; Kuick R; Brenner DE; Hanash SM
Proteomics; 2003 Nov; 3(11):2108-15. PubMed ID: 14595809
[TBL] [Abstract][Full Text] [Related]
7. The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line.
Li C; Kim HY; Vuong H; Patwa T; Pal M; Brand RE; Simeone DM; Lubman DM
Cancer Biomark; 2010; 7(1):25-37. PubMed ID: 21045262
[TBL] [Abstract][Full Text] [Related]
8. Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.
Pereira-Faca SR; Kuick R; Puravs E; Zhang Q; Krasnoselsky AL; Phanstiel D; Qiu J; Misek DE; Hinderer R; Tammemagi M; Landi MT; Caporaso N; Pfeiffer R; Edelstein C; Goodman G; Barnett M; Thornquist M; Brenner D; Hanash SM
Cancer Res; 2007 Dec; 67(24):12000-6. PubMed ID: 18089831
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma.
Chen G; Wang X; Yu J; Varambally S; Yu J; Thomas DG; Lin MY; Vishnu P; Wang Z; Wang R; Fielhauer J; Ghosh D; Giordano TJ; Giacherio D; Chang AC; Orringer MB; El-Hefnawy T; Bigbee WL; Beer DG; Chinnaiyan AM
Cancer Res; 2007 Apr; 67(7):3461-7. PubMed ID: 17409457
[TBL] [Abstract][Full Text] [Related]
10. Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigens.
Stempfer R; Syed P; Vierlinger K; Pichler R; Meese E; Leidinger P; Ludwig N; Kriegner A; Nöhammer C; Weinhäusel A
BMC Cancer; 2010 Nov; 10():627. PubMed ID: 21078204
[TBL] [Abstract][Full Text] [Related]
11. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer.
Brichory F; Beer D; Le Naour F; Giordano T; Hanash S
Cancer Res; 2001 Nov; 61(21):7908-12. PubMed ID: 11691811
[TBL] [Abstract][Full Text] [Related]
12. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.
Gao WM; Kuick R; Orchekowski RP; Misek DE; Qiu J; Greenberg AK; Rom WN; Brenner DE; Omenn GS; Haab BB; Hanash SM
BMC Cancer; 2005 Aug; 5():110. PubMed ID: 16117833
[TBL] [Abstract][Full Text] [Related]
13. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
14. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays.
Gnjatic S; Wheeler C; Ebner M; Ritter E; Murray A; Altorki NK; Ferrara CA; Hepburne-Scott H; Joyce S; Koopman J; McAndrew MB; Workman N; Ritter G; Fallon R; Old LJ
J Immunol Methods; 2009 Feb; 341(1-2):50-8. PubMed ID: 19041653
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
[TBL] [Abstract][Full Text] [Related]
17. The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray.
Patwa TH; Li C; Poisson LM; Kim HY; Pal M; Ghosh D; Simeone DM; Lubman DM
Electrophoresis; 2009 Jun; 30(12):2215-26. PubMed ID: 19582723
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma.
Li Y; Li CQ; Guo SJ; Guo W; Jiang HW; Li HC; Tao SC
EBioMedicine; 2020 Mar; 53():102674. PubMed ID: 32113159
[TBL] [Abstract][Full Text] [Related]
19. Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer.
Anderson KS; Ramachandran N; Wong J; Raphael JV; Hainsworth E; Demirkan G; Cramer D; Aronzon D; Hodi FS; Harris L; Logvinenko T; LaBaer J
J Proteome Res; 2008 Apr; 7(4):1490-9. PubMed ID: 18311903
[TBL] [Abstract][Full Text] [Related]
20. Serum p53 antibodies as early markers of lung cancer.
Lubin R; Zalcman G; Bouchet L; Trédanel J; Legros Y; Cazals D; Hirsch A; Soussi T
Nat Med; 1995 Jul; 1(7):701-2. PubMed ID: 7585154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
